Low ankle-brachial index and the development of rapid estimated GFR decline and CKD

Meredith C Foster1, Nimrta Ghuman, Shih-Jen Hwang

  • 1National Heart, Lung, and Blood Institute's (NHLBI's) Framingham Heart Study, Framingham, MA, USA.

Insights

Low ankle-brachial index (ABI), a marker of atherosclerosis, is linked to a higher risk of rapid kidney function decline. This suggests systemic vascular disease predicts worsening kidney health.

Area of Science:

  • Cardiology
  • Nephrology
  • Vascular Medicine

Background:

  • Low ankle-brachial index (ABI) correlates with elevated serum creatinine.
  • The association between low ABI and rapid estimated glomerular filtration rate (eGFR) decline, stage 3 chronic kidney disease (CKD), or microalbuminuria remains unclear.

Purpose of the Study:

  • To investigate the association between low ABI and the development of rapid eGFR decline, incident stage 3 CKD, and incident microalbuminuria.

Main Methods:

  • Prospective cohort study utilizing data from the Framingham Offspring cohort.
  • Ankle-brachial index (ABI) categorized as normal, low-normal, and low (≤0.9).
  • Estimated glomerular filtration rate (eGFR) calculated using CKD-EPI equation; microalbuminuria assessed via urinary albumin-creatinine ratio (UACR).

Main Results:

  • Low ABI was significantly associated with a 3.60-fold increased odds of rapid eGFR decline after multivariable adjustment.
  • A trend for increased odds of incident stage 3 CKD was observed with low ABI, though not statistically significant after full adjustment.
  • Low ABI was associated with increased odds of microalbuminuria, but this association attenuated with further adjustment.

Conclusions:

  • Low ABI is a significant predictor of rapid eGFR decline.
  • The findings suggest that systemic atherosclerosis, indicated by low ABI, is associated with decreased kidney function.
  • Further research may clarify the relationship between low ABI and CKD progression and microalbuminuria.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...